Literature DB >> 2929871

Correlation of otosclerotic foci and degenerative changes in the organ of Corti and spiral ganglion.

O T Kwok1, J B Nadol.   

Abstract

Statistical analyses of histopathologic findings in the cochlea and spiral ganglion of 37 temporal bones with otosclerosis, 12 controls of similar age, and seven controls with normal hearing were performed. In temporal bones with otosclerosis there was significant atrophy of the spiral ligament and stria vascularis in regions with endosteal involvement by otosclerosis, compared with regions without endosteal involvement (P less than .0001). There was more generalized atrophy of the stria vascularis in cochleae with two or more sites of endosteal involvement by otosclerosis than in cochleae with only one site of endosteal involvement (P less than .02), cochleae in temporal bones with otosclerosis but without endosteal involvement (P less than .05), or cochleae of controls of similar age (P less than .007). In addition, there was more atrophy of the spiral ligament in cochleae with two or more sites of endosteal involvement than in cochleae of similar age from the control group (P less than .03). In temporal bones with otosclerosis, there was no significant difference in counts of outer hair cells and density of spiral ganglion cells between regions demonstrating endosteal involvement by otosclerosis and regions without such involvement. However, total outer hair cell counts were lower in cochleae with two or more sites of endosteal involvement of otosclerosis than in cochleae with one site of endosteal involvement (P less than .04), cochleae in temporal bones with otosclerosis but without endosteal involvement (P less than .02), or cochleae from individuals of similar age but without otosclerosis (P = .05). Comparison of the mean bone conduction threshold, as measured in life, in temporal bones with otosclerosis compared with the air conduction threshold in aged-matched controls, demonstrated that only cochleae with two or more sites of endosteal involvement had a mild but statistically significant (P = .05) decrease in hearing. There was no evidence to support the concept that otosclerotic foci without stapedial fixation frequently cause significant degeneration of the cochlea or elevation of bone conduction thresholds.

Entities:  

Mesh:

Year:  1989        PMID: 2929871     DOI: 10.1016/0196-0709(89)90086-0

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  6 in total

1.  Unbiased stereological estimation of the spiral ligament and stria vascularis volumes in aging and Ménière's disease using archival human temporal bones.

Authors:  Gail Ishiyama; Joshua Tokita; Ivan Lopez; Yong Tang; Akira Ishiyama
Journal:  J Assoc Res Otolaryngol       Date:  2006-12-08

2.  Third-generation bisphosphonates for treatment of sensorineural hearing loss in otosclerosis.

Authors:  Alicia M Quesnel; Margaret Seton; Saumil N Merchant; Christopher Halpin; Michael J McKenna
Journal:  Otol Neurotol       Date:  2012-10       Impact factor: 2.311

3.  Selective activation of nuclear factor kappa B in the cochlea by sensory and inflammatory stress.

Authors:  J C Adams; B Seed; N Lu; A Landry; R J Xavier
Journal:  Neuroscience       Date:  2009-03-11       Impact factor: 3.590

4.  Third-generation bisphosphonates for cochlear otosclerosis stabilizes sensorineural hearing loss in long-term follow-up.

Authors:  Taha A Jan; Aaron K Remenschneider; Christopher Halpin; Margaret Seton; Michael J McKenna; Alicia M Quesnel
Journal:  Laryngoscope Investig Otolaryngol       Date:  2017-09-21

5.  OTOPLAN, Cochlear Implant, and Far-Advanced Otosclerosis: Could the Use of Software Improve the Surgical Final Indication?

Authors:  Giampietro Ricci; Ruggero Lapenna; Valeria Gambacorta; Antonio Della Volpe; Mario Faralli; Arianna Di Stadio
Journal:  J Int Adv Otol       Date:  2022-01       Impact factor: 1.316

6.  Surgical considerations and audiological results of cochlear implantation in patients with otosclerosis

Authors:  Tolgahan Çatli; Taşkin Tokat; Ergül Başaran Bozkurt; Zehra Hilal Adibelli; Uğurtan Ergün; Enver Altaş; Levent Olgun
Journal:  Turk J Med Sci       Date:  2020-06-23       Impact factor: 0.973

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.